Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1963408Generated: October 29, 2026

Hydrochloric Acid → cis-Methyl 2-(2,4-difluorophenyl)-4-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate

https://huagongshe.com/reaction/1963408

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
Reactant1,1'-CarbonyldiimidazoleHCID 68263—
ReactantPotassium ethyl malonateHCID 3446434—
ReactantMagnesium ChlorideHCID 5360315—
ReactantHCID 66731973HCID 66731973—
SolventWaterHCID 962—
SolventEthyl AcetateHCID 8857—
SolventHeptaneHCID 8900—
Solventtert-Butyl methyl etherHCID 15413—
SolventHCID 178479889HCID 178479889—
Productcis-Methyl 2-(2,4-difluorophenyl)-4-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylateHCID 13173040232%

Reaction Steps

2-(2,4-Difluorophenyl)-1-(methoxycarbonyl)piperidine-4-carboxylic acid (2.20 g, 7.35 mmol) (reference compound 19) was dissolved in methyl THF (70 mL), then di(1H-imidazol-1-yl)methanone (2.146 g, 13.23 mmol) was added. The mixture was stirred at room temperature under nitrogen for 5 h (flask 1). In a separate flask potassium 3-ethoxy-3-oxopropanoate (2.252 g, 13.23 mmol) was suspended in methyl THF (70.0 mL), then magnesium chloride (1.260 g, 13.23 mmol) was added. The suspension was stirred at 50° C. under nitrogen for 5 h using a large magnetic stirring bar (flask 2). After the 3 h, the contents of flask 1 was transferred into flask 2. The resulting white suspension was stirred under nitrogen at room temperature overnight. The mixture was acidified to pH 1 with 3.8 M HCl, then MTBE (50 mL) and water (50 mL) was added. The phases were separated and the organic layer was washed with water, satd NaHCO3 and brine. The organic layer was dried over Na2SO4, filtered and evaporated leaving a slightly yellow oil. The product was flashed on Biotage (340 g) with 1 CV EtOAc in heptane (20%) followed by a gradient of 20-60% EtOAc in n-heptane (8 CV). The column was conditioned at 20% EtOAc in -n-heptane (1 CV). Cis-methyl 2-(2,4-difluorophenyl)-4-(3-ethoxy-3-oxopropanoyl)piperidine-1-carboxylate (870 mg, 32%) was isolated. MS m/z 370 (M+H)+

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08415378B2
Source datasetuspto-grants-2013_04
ORD IDord-011f1b9d477a4304bb1c5001870bfe52
Source noteuspto-grants-2013_04